Image

External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery

Recruiting
23 - 69 years of age
Female
Phase N/A

Powered by AI

Overview

This multicentre randomized controlled trial aims to evaluate a new breast reconstruction technique- autologous fat transfer (AFT). Female patients with breast cancer schedule to receive a mastectomy (or having undergone mastectomy in the past) will be randomized to undergo breast reconstruction with either AFT with the EVEBRA device(intervention group) or AFT without the EVEBRA device (control group). AFT will be evaluated in terms of volume, quality of life, aesthetic result, complications and oncological safety.

Eligibility

Inclusion Criteria:

  • Female
  • Age 23-69
  • BMI 18-35 - stable weight, no fluctuations
  • Have undergone a total mastectomy at least 3 months prior the study, whether therapeutic or prophylactic, whether unilateral or bilateral, with no resection of the pectoralis muscle
  • Agrees to have reconstruction at the time of study involving only autologous fat grafting (AFT)
  • Assessed by surgeon to have enough donor fat
  • Passes a 20-minutes tolerance test with EVEBRA Device. (Patient will be fitted, instructed on the use, and given the EVEBRA Device to try in the office for 20 minutes. She passes if she tolerates its use, feels comfortable wearing it, and is able to comply with the required wear of the device.)

Exclusion Criteria:

  • untreated breast cancer
  • history of radiation therapy on the involved breast, even if it was part of a previous breast conservation procedure
  • completed chemotherapy course less than 2 months prior (acceptable to still be on aromatase inhibitors)
  • except for the biopsy leading to the diagnosis of cancer, had surgery to breast prior to the mastectomy (e.g., multiple biopsies, implant augmentation, mastopexy, fat grating)
  • had mastectomy wound healing complications, e.g., seroma, wound breakdown, infection
  • mastectomy defect/scar has significant skin excess and deep folds adherent to the chest wall
  • has a pacemaker or aneurysm clips
  • pregnancy or breastfeeding
  • had a cardiac stent placed within the last 2 months
  • claustrophobic, as reported by patient
  • known current substance abuse, as reported by patient
  • history of silicone allergy, as reported by patient
  • history of Gadolinium allergy, as reported by patient
  • history of lidocaine allergy, as reported by patient
  • bleeding diathesis, whether primary or iatrogenic, as reported by patient cigarette smoker and/or Smokeless cigarette smokers, as reported by patient
  • medical conditions that preclude breast reconstruction including uncontrolled hypertension or diabetes, renal failure, steroid dependent asthma, and on immunosuppressant medications, as reported by patient

Study details

Breast Cancer Female

NCT05003635

Maastricht University Medical Center

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.